AbCellera Biologics Inc. ABCL Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate.
The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s effective income tax rate reconciliation at federal statutory income tax rate, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s effective income tax rate reconciliation at federal statutory income tax rate, amount?
- AbCellera Biologics Inc. (ABCL) reported effective income tax rate reconciliation at federal statutory income tax rate, amount of -$13.53M in Q4 2024.
- How has AbCellera Biologics Inc.'s effective income tax rate reconciliation at federal statutory income tax rate, amount changed year-over-year?
- AbCellera Biologics Inc.'s effective income tax rate reconciliation at federal statutory income tax rate, amount decreased by 15.2% year-over-year, from -$11.75M to -$13.53M.
- What does effective income tax rate reconciliation at federal statutory income tax rate, amount mean?
- This represents the total income tax provision or benefit derived from applying the federal statutory rate to pre-tax earnings. It is a foundational component of the tax reconciliation table used to explain the difference between statutory and effective tax rates. It helps analysts understand the core tax liability before specific adjustments are applied.